+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Marine Pharmaceuticals Market 2022-2026

  • ID: 5300882
  • Report
  • May 2022
  • Region: Global
  • 120 Pages
  • TechNavio
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The market is driven by licensing agreements, the growing prevalence of chronic diseases, and the vast availability of raw materials

FEATURED COMPANIES

  • Amway Corp.
  • BeyondSpring Inc.
  • Croda International PLC
  • GlaxoSmithKline PLC
  • Jazz Pharmaceuticals PLC
  • Merck KGaA
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The marine pharmaceuticals market is poised to grow by $1.56 billion during 2022-2026, accelerating at a CAGR of 7.73% during the forecast period.

This report on the marine pharmaceuticals market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment.

The market is driven by licensing agreements, the growing prevalence of chronic diseases, and the vast availability of raw materials.

The marine pharmaceuticals market analysis includes the product segment and geographic landscape.

The marine pharmaceuticals market is segmented as below:


By Product

  • Oncology
  • Cardiovascular
  • Anti-infectives
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the marine peptides as anti-infectives as one of the prime reasons driving the marine pharmaceuticals market growth during the next few years. Also, research for anti-inflammatory compounds from marine sources and increasing clinical trials will lead to sizable demand in the market.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. This report covers the following areas:
  • Marine pharmaceuticals market sizing
  • Marine pharmaceuticals market forecast
  • Marine pharmaceuticals market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, the report provides a detailed analysis of several leading marine pharmaceuticals market vendors that include Amway Corp., BASF SE, BeyondSpring Inc., BioMarin Pharmaceutical Inc., Bristol Myers Squibb Co., Eisai Co. Ltd., GlaxoSmithKline Plc, Guardian Industries Corp., Jazz Pharmaceuticals Plc, Koninklijke DSM NV, Merck KGaA, Nordic Naturals Inc., Pelagia EPAX, Pfizer Inc., Pharma Marine AS, PharmaMar SA, Seagen Inc., and Croda International Plc. Also, the marine pharmaceuticals market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The analyst's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Amway Corp.
  • BeyondSpring Inc.
  • Croda International PLC
  • GlaxoSmithKline PLC
  • Jazz Pharmaceuticals PLC
  • Merck KGaA

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Product
5.1 Market segments
Exhibit 24: Chart on Product - Market share 2021-2026 (%)
Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
5.2 Comparison by Product
Exhibit 26: Chart on Comparison by Product
Exhibit 27: Data Table on Comparison by Product
5.3 Oncology - Market size and forecast 2021-2026
Exhibit 28: Chart on Oncology - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Oncology - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Oncology - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Oncology - Year-over-year growth 2021-2026 (%)
5.4 Cardiovascular - Market size and forecast 2021-2026
Exhibit 32: Chart on Cardiovascular - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Cardiovascular - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Cardiovascular - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Cardiovascular - Year-over-year growth 2021-2026 (%)
5.5 Anti-infectives - Market size and forecast 2021-2026
Exhibit 36: Chart on Anti-infectives - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Anti-infectives - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Anti-infectives - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Anti-infectives - Year-over-year growth 2021-2026 (%)
5.6 Others - Market size and forecast 2021-2026
Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
5.7 Market opportunity by Product
Exhibit 44: Market opportunity by Product ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 48: Chart on Geographic comparison
Exhibit 49: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 China - Market size and forecast 2021-2026
Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
7.10 UK - Market size and forecast 2021-2026
Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.11 Canada - Market size and forecast 2021-2026
Exhibit 82: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 83: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 84: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 85: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 86: Market opportunity By Geographical Landscape ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 87: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 89: Overview on factors of disruption
9.4 Industry risks
Exhibit 90: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 91: Vendors covered
10.2 Market positioning of vendors
Exhibit 92: Matrix on vendor position and classification
10.3 BeyondSpring Inc.
Exhibit 93: BeyondSpring Inc. - Overview
Exhibit 94: BeyondSpring Inc. - Product / Service
Exhibit 95: BeyondSpring Inc. - Key offerings
10.4 BioMarin Pharmaceutical Inc.
Exhibit 96: BioMarin Pharmaceutical Inc. - Overview
Exhibit 97: BioMarin Pharmaceutical Inc. - Product / Service
Exhibit 98: BioMarin Pharmaceutical Inc. - Key offerings
10.5 Bristol Myers Squibb Co.
Exhibit 99: Bristol Myers Squibb Co. - Overview
Exhibit 100: Bristol Myers Squibb Co. - Product / Service
Exhibit 101: Bristol Myers Squibb Co. - Key offerings
10.6 Eisai Co. Ltd.
Exhibit 102: Eisai Co. Ltd. - Overview
Exhibit 103: Eisai Co. Ltd. - Business segments
Exhibit 104: Eisai Co. Ltd. - Key offerings
Exhibit 105: Eisai Co. Ltd. - Segment focus
10.7 GlaxoSmithKline Plc
Exhibit 106: GlaxoSmithKline Plc - Overview
Exhibit 107: GlaxoSmithKline Plc - Business segments
Exhibit 108: GlaxoSmithKline Plc - Key news
Exhibit 109: GlaxoSmithKline Plc - Key offerings
Exhibit 110: GlaxoSmithKline Plc - Segment focus
10.8 Jazz Pharmaceuticals Plc
Exhibit 111: Jazz Pharmaceuticals Plc - Overview
Exhibit 112: Jazz Pharmaceuticals Plc - Product / Service
Exhibit 113: Jazz Pharmaceuticals Plc - Key news
Exhibit 114: Jazz Pharmaceuticals Plc - Key offerings
10.9 Nordic Naturals Inc.
Exhibit 115: Nordic Naturals Inc. - Overview
Exhibit 116: Nordic Naturals Inc. - Product / Service
Exhibit 117: Nordic Naturals Inc. - Key offerings
10.10 Pfizer Inc.
Exhibit 118: Pfizer Inc. - Overview
Exhibit 119: Pfizer Inc. - Product / Service
Exhibit 120: Pfizer Inc. - Key news
Exhibit 121: Pfizer Inc. - Key offerings
10.11 PharmaMar SA
Exhibit 122: PharmaMar SA - Overview
Exhibit 123: PharmaMar SA - Business segments
Exhibit 124: PharmaMar SA - Key news
Exhibit 125: PharmaMar SA - Key offerings
Exhibit 126: PharmaMar SA - Segment focus
10.12 Seagen Inc.
Exhibit 127: Seagen Inc. - Overview
Exhibit 128: Seagen Inc. - Product / Service
Exhibit 129: Seagen Inc. - Key offerings
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 130: Inclusions checklist
Exhibit 131: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 132: Currency conversion rates for US$
11.4 Research methodology
Exhibit 133: Research methodology
Exhibit 134: Validation techniques employed for market sizing
Exhibit 135: Information sources
11.5 List of abbreviations
Exhibit 136: List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 5: Executive Summary - Chart on Market Segmentation by Product
Exhibit 6: Executive Summary - Chart on Incremental Growth
Exhibit 7: Executive Summary - Data Table on Incremental Growth
Exhibit 8: Executive Summary - Chart on Vendor Market Positioning
Exhibit 9: Parent market
Exhibit 10: Market Characteristics
Exhibit 11: Offerings of vendors included in the market definition
Exhibit 12: Market segments
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
Exhibit 24: Chart on Product - Market share 2021-2026 (%)
Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
Exhibit 26: Chart on Comparison by Product
Exhibit 27: Data Table on Comparison by Product
Exhibit 28: Chart on Oncology - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Oncology - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Oncology - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Oncology - Year-over-year growth 2021-2026 (%)
Exhibit 32: Chart on Cardiovascular - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Cardiovascular - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Cardiovascular - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Cardiovascular - Year-over-year growth 2021-2026 (%)
Exhibit 36: Chart on Anti-infectives - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Anti-infectives - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Anti-infectives - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Anti-infectives - Year-over-year growth 2021-2026 (%)
Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibit 44: Market opportunity by Product ($ million)
Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 48: Chart on Geographic comparison
Exhibit 49: Data Table on Geographic comparison
Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibit 82: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 83: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 84: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 85: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 86: Market opportunity By Geographical Landscape ($ million)
Exhibit 87: Impact of drivers and challenges in 2021 and 2026
Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
Exhibit 89: Overview on factors of disruption
Exhibit 90: Impact of key risks on business
Exhibit 91: Vendors covered
Exhibit 92: Matrix on vendor position and classification
Exhibit 93: BeyondSpring Inc. - Overview
Exhibit 94: BeyondSpring Inc. - Product / Service
Exhibit 95: BeyondSpring Inc. - Key offerings
Exhibit 96: BioMarin Pharmaceutical Inc. - Overview
Exhibit 97: BioMarin Pharmaceutical Inc. - Product / Service
Exhibit 98: BioMarin Pharmaceutical Inc. - Key offerings
Exhibit 99: Bristol Myers Squibb Co. - Overview
Exhibit 100: Bristol Myers Squibb Co. - Product / Service
Exhibit 101: Bristol Myers Squibb Co. - Key offerings
Exhibit 102: Eisai Co. Ltd. - Overview
Exhibit 103: Eisai Co. Ltd. - Business segments
Exhibit 104: Eisai Co. Ltd. - Key offerings
Exhibit 105: Eisai Co. Ltd. - Segment focus
Exhibit 106: GlaxoSmithKline Plc - Overview
Exhibit 107: GlaxoSmithKline Plc - Business segments
Exhibit 108: GlaxoSmithKline Plc - Key news
Exhibit 109: GlaxoSmithKline Plc - Key offerings
Exhibit 110: GlaxoSmithKline Plc - Segment focus
Exhibit 111: Jazz Pharmaceuticals Plc - Overview
Exhibit 112: Jazz Pharmaceuticals Plc - Product / Service
Exhibit 113: Jazz Pharmaceuticals Plc - Key news
Exhibit 114: Jazz Pharmaceuticals Plc - Key offerings
Exhibit 115: Nordic Naturals Inc. - Overview
Exhibit 116: Nordic Naturals Inc. - Product / Service
Exhibit 117: Nordic Naturals Inc. - Key offerings
Exhibit 118: Pfizer Inc. - Overview
Exhibit 119: Pfizer Inc. - Product / Service
Exhibit 120: Pfizer Inc. - Key news
Exhibit 121: Pfizer Inc. - Key offerings
Exhibit 122: PharmaMar SA - Overview
Exhibit 123: PharmaMar SA - Business segments
Exhibit 124: PharmaMar SA - Key news
Exhibit 125: PharmaMar SA - Key offerings
Exhibit 126: PharmaMar SA - Segment focus
Exhibit 127: Seagen Inc. - Overview
Exhibit 128: Seagen Inc. - Product / Service
Exhibit 129: Seagen Inc. - Key offerings
Exhibit 130: Inclusions checklist
Exhibit 131: Exclusions checklist
Exhibit 132: Currency conversion rates for US$
Exhibit 133: Research methodology
Exhibit 134: Validation techniques employed for market sizing
Exhibit 135: Information sources
Exhibit 136: List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Amway Corp.
  • BeyondSpring Inc.
  • Croda International PLC
  • GlaxoSmithKline PLC
  • Jazz Pharmaceuticals PLC
  • Merck KGaA
The analyst recognizes the following companies as the key players in the global marine pharmaceuticals market: Amway Corp., BASF SE, BeyondSpring Inc., BioMarin Pharmaceutical Inc., Bristol Myers Squibb Co., Eisai Co. Ltd., GlaxoSmithKline Plc, Guardian Industries Corp., Jazz Pharmaceuticals Plc, Koninklijke DSM NV, Merck KGaA, Nordic Naturals Inc., Pelagia EPAX, Pfizer Inc., Pharma Marine AS, PharmaMar SA, Seagen Inc., and Croda International Plc.

Commenting on the report, an analyst said: ''The latest trend gaining momentum in the market is marine peptides as anti-infectives.''

According to the report, one of the major drivers for this market is the licensing agreements.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Amway Corp.
  • BASF SE
  • BeyondSpring Inc.
  • BioMarin Pharmaceutical Inc.
  • Bristol Myers Squibb Co.
  • Eisai Co. Ltd.
  • GlaxoSmithKline PLC
  • Guardian Industries Corp.
  • Jazz Pharmaceuticals PLC
  • Koninklijke DSM NV
  • Merck KGaA
  • Nordic Naturals Inc.
  • Pelagia EPAX
  • Pfizer Inc.
  • Pharma Marine AS
  • PharmaMar SA
  • Seagen Inc.
  • Croda International PLC
Note: Product cover images may vary from those shown